임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1/2상모집 중단 (진행 중)· Active Noninfectious Uveitis Affecting the Posterior SegmentA Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
리드: 리제네론
- 1/2상모집 중단 (진행 중)· Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaA Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
리드: 암젠
- 1/2상모집 중단 (진행 중)· Influenza AA Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Moderate to Severe Ulcerative ColitisA Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis
리드: 로슈
- 1/2상모집 중단 (진행 중)· MelanomaA Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
리드: GSK
- 1/2상모집 중단 (진행 중)· Advanced Breast CancerClinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer
협력: 길리어드
- 1/2상모집 중단 (진행 중)· Melanoma MetastaticDifferent Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma
협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Neovascular Age-related Macular DegenerationA Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration
리드: 사노피
- 1/2상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
- 1/2상모집 중단 (진행 중)· Human Metapneumovirus ImmunizationStudy of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older
리드: 사노피
- 1/2상모집 중단 (진행 중)· Meningococcal ImmunizationSafety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
리드: 사노피
- 1/2상모집 중단 (진행 중)· MSI-H/dMMR Gastroesophageal-junction CancerA Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.
협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Refractory Systemic Lupus ErythematosusA Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus
협력: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Non-small Cell Lung Cancer (NSCLC)Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
협력: 리제네론
- 1/2상모집 중단 (진행 중)· Metastatic Urothelial CarcinomaA Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)
리드: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Myeloid LeukemiaA Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia
협력: GSK
- 1/2상모집 중단 (진행 중)· Ovarian CancerA Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors
리드: 다케다
- 1/2상모집 중단 (진행 중)· Bladder CancerA Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
리드: 머크(MSD) · 협력: 모더나
- 1/2상모집 중단 (진행 중)· Breast CancerA Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
리드: 화이자
- 1/2상모집 중단 (진행 중)· Glioblastoma MultiformeT Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Hepatocellular CarcinomaA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Untreated Myelodysplastic SyndromeOral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
협력: 애브비, BMS
- 1/2상모집 중단 (진행 중)· Recurrent Vulvovaginal CandidiasisAssessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
협력: GSK
- 1/2상모집 중단 (진행 중)· Solid TumorsBI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Relapsed or Refractory T-cell LymphomasA Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
리드: BMS
- 1/2상모집 중단 (진행 중)· Pulmonary Arterial HypertensionA Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
리드: 화이자
- 1/2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaTwo-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
협력: GSK
- 1/2상모집 중단 (진행 중)· Overweight and ObesityA Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight
리드: 아스트라제네카
- 1/2상모집 중단 (진행 중)· Norovirus Acute GastroenteritisStudy to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
리드: 모더나
- 1/2상모집 중단 (진행 중)· Atypical Teratoid Rhabdoid TumorTazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
협력: BMS
- 1/2상모집 중단 (진행 중)· TuberculosisSafety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers
리드: 바이오엔테크
- 1/2상모집 중단 (진행 중)· Lung CancerAmivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
협력: 얀센(J&J)
- 1/2상모집 중단 (진행 중)· Metastatic Urothelial CarcinomaA Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)
리드: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorsA Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
리드: BMS
- 1/2상모집 중단 (진행 중)· Solid Tumor, AdultA Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
협력: 리제네론
- 1/2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer
리드: 얀센(J&J)
- 1/2상모집 중단 (진행 중)· Type 1 DiabetesA Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
리드: 버텍스
- 1/2상모집 중단 (진행 중)· Clostridoides Difficile Associated DiseaseTo Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
리드: 화이자
- 1/2상모집 중단 (진행 중)· Systemic Lupus ErythematosusAn Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus
리드: 노바티스
- 1/2상모집 중단 (진행 중)· Cystic FibrosisA Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
리드: 버텍스
- 1/2상모집 중단 (진행 중)· Herpes ZosterA Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age
리드: 모더나
- 1/2상모집 중단 (진행 중)· Multiple MyelomaCOMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
협력: BMS
- 1/2상모집 중단 (진행 중)· Esophageal CancerOral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
리드: 얀센(J&J)
- 1/2상모집 중단 (진행 중)· AL AmyloidosisVenetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
협력: 로슈
- 1/2상모집 중단 (진행 중)· KRAS G12C Mutant Solid TumorsPlatform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
리드: 노바티스
- 1/2상모집 중단 (진행 중)· Advanced or Metastatic Solid TumorsA Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors
협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· MelanomaA Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
협력: 머크(MSD)
- 1/2상모집 중단 (진행 중)· Refractory Acute Lymphoblastic LeukemiaTrial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
협력: 애브비
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.